Norway's Oil Fund to Abstain From Novo Nordisk Board Vote

Dow Jones

11/10

By Dominic Chopping

Norway's sovereign-wealth fund will abstain from voting on new board members at Novo Nordisk's extraordinary shareholders' meeting later this week.

Danish drugmaker Novo Nordisk said last month it will replace its chairman and other board members after its controlling shareholder pushed for more changes to revive the company's success in the weight-loss market.

Chairman Helge Lund, Vice Chair Henrik Poulsen and five independent directors are being replaced and an extraordinary general meeting held on Friday to vote on new board members.

The company's majority shareholder, the Novo Nordisk Foundation, is proposing new members for election, including former Novo Nordisk Chief Executive Lars Rebien Sorensen as chair and Cees de Jong as vice chair.

The Norwegian wealth fund, commonly known as the oil fund, said Monday that it will abstain from voting on the new board appointments, including the chair and vice chair. It didn't provide a reason for the decision.

The oil fund holds a 1.79% stake in Novo Nordisk, valued at around $5.54 billion at June 30.

Write to Dominic Chopping at dominic.chopping@wsj.com

(END) Dow Jones Newswires

November 10, 2025 03:29 ET (08:29 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

应版权方要求，你需要登录查看该内容

登录 / 注册

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2582752823"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2582752823\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2582752823?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-10 16:29","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2582752823","market":"hk","top_or_hot":-1,"title":"Norway's Oil Fund to Abstain From Novo Nordisk Board Vote","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  By Dominic Chopping \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Norway's sovereign-wealth fund will abstain from voting on new board members at <a href=\"https://laohu8.com/S/NVO\">Novo Nordisk</a>'s extraordinary shareholders' meeting later this week. \n</p>\n<p>\n  Danish drugmaker Novo Nordisk said last month it will replace its chairman and other board members after its controlling shareholder pushed for more changes to revive the company's success in the weight-loss market. \n</p>\n<p>\n  Chairman Helge Lund, Vice Chair Henrik Poulsen and five independent directors are being replaced and an extraordinary general meeting held on Friday to vote on new board members. \n</p>\n<p>\n  The company's majority shareholder, the Novo Nordisk Foundation, is proposing new members for election, including former Novo Nordisk Chief Executive Lars Rebien Sorensen as chair and Cees de Jong as vice chair. \n</p>\n<p>\n  The Norwegian wealth fund, commonly known as the oil fund, said Monday that it will abstain from voting on the new board appointments, including the chair and vice chair. It didn't provide a reason for the decision. \n</p>\n<p>\n  The oil fund holds a 1.79% stake in Novo Nordisk, valued at around $5.54 billion at June 30. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Write to Dominic Chopping at dominic.chopping@wsj.com \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  November 10, 2025 03:29 ET (08:29 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Norway's Oil Fund to Abstain From Novo Nordisk Board Vote</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNorway's Oil Fund to Abstain From Novo Nordisk Board Vote\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2025-11-10 16:29</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  By Dominic Chopping \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Norway's sovereign-wealth fund will abstain from voting on new board members at <a href=\"https://laohu8.com/S/NVO\">Novo Nordisk</a>'s extraordinary shareholders' meeting later this week. \n</p>\n<p>\n  Danish drugmaker Novo Nordisk said last month it will replace its chairman and other board members after its controlling shareholder pushed for more changes to revive the company's success in the weight-loss market. \n</p>\n<p>\n  Chairman Helge Lund, Vice Chair Henrik Poulsen and five independent directors are being replaced and an extraordinary general meeting held on Friday to vote on new board members. \n</p>\n<p>\n  The company's majority shareholder, the Novo Nordisk Foundation, is proposing new members for election, including former Novo Nordisk Chief Executive Lars Rebien Sorensen as chair and Cees de Jong as vice chair. \n</p>\n<p>\n  The Norwegian wealth fund, commonly known as the oil fund, said Monday that it will abstain from voting on the new board appointments, including the chair and vice chair. It didn't provide a reason for the decision. \n</p>\n<p>\n  The oil fund holds a 1.79% stake in Novo Nordisk, valued at around $5.54 billion at June 30. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Write to Dominic Chopping at dominic.chopping@wsj.com \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  November 10, 2025 03:29 ET (08:29 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"NVO","symbol_name":"诺和诺德","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2582752823","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2582752823","pubTimestamp":1762763340,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"Norway's sovereign-wealth fund will abstain from voting on new board members at Novo Nordisk's extraordinary shareholders' meeting later this week.Danish drugmaker Novo Nordisk said last month it will replace its chairman and other board members after its controlling shareholder pushed for more changes to revive the company's success in the weight-loss market.Chairman Helge Lund, Vice Chair Henrik Poulsen and five independent directors are being replaced and an extraordinary general meeting held on Friday to vote on new board members.The company's majority shareholder, the Novo Nordisk Foundation, is proposing new members for election, including former Novo Nordisk Chief Executive Lars Rebien Sorensen as chair and Cees de Jong as vice chair.The Norwegian wealth fund, commonly known as the oil fund, said Monday that it will abstain from voting on the new board appointments, including the chair and vice chair. It didn't provide a reason for the decision.The oil fund holds a 1.79% stake i","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"NVO":"诺和诺德","LU1093756168.USD":"FRANKLIN K2 ALTERNATIVE STRATEGIES \"A\" (USD) ACC","BK4588":"碎股","BK4585":"ETF&股票定投概念","IE00BKVL7J92.USD":"Legg Mason ClearBridge - US Equity Sustainability Leaders A Acc USD","IE00BZ1G4Q59.USD":"LEGG MASON CLEARBRIDGE US EQUITY SUSTAINABILITY LEADER \"A\"(USD) INC (A)","BK4532":"文艺复兴科技持仓","LU0154236417.USD":"BGF US FLEXIBLE EQUITY \"A2\" ACC","BK4599":"减肥药","LU1093756325.SGD":"FTIF - Franklin K2 Alt Strat Fd A (acc) SGD-H1","BK4007":"制药"},"translate_title":"挪威石油基金将在诺和诺德董事会投票中弃权","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"NVO":1.5},"content_text":"By Dominic Chopping \n\n\n \n\n\n  Norway's sovereign-wealth fund will abstain from voting on new board members at Novo Nordisk's extraordinary shareholders' meeting later this week. \n\n\n  Danish drugmaker Novo Nordisk said last month it will replace its chairman and other board members after its controlling shareholder pushed for more changes to revive the company's success in the weight-loss market. \n\n\n  Chairman Helge Lund, Vice Chair Henrik Poulsen and five independent directors are being replaced and an extraordinary general meeting held on Friday to vote on new board members. \n\n\n  The company's majority shareholder, the Novo Nordisk Foundation, is proposing new members for election, including former Novo Nordisk Chief Executive Lars Rebien Sorensen as chair and Cees de Jong as vice chair. \n\n\n  The Norwegian wealth fund, commonly known as the oil fund, said Monday that it will abstain from voting on the new board appointments, including the chair and vice chair. It didn't provide a reason for the decision. \n\n\n  The oil fund holds a 1.79% stake in Novo Nordisk, valued at around $5.54 billion at June 30. \n\n\n \n\n\n  Write to Dominic Chopping at dominic.chopping@wsj.com \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  November 10, 2025 03:29 ET (08:29 GMT)\n\n\n  Copyright (c) 2025 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}